Norwalk Company Named Murphy's 'Innovator Of The Month'

NORWALK, CT — Norwalk-based BioWave has been named U.S. Sen. Chris Murphy's "Innovator of the Month" for April 2022.

BioWave is "a patented smarter pain blocking technology that provides relief from severe pain," according to a news release. "BioWave devices deliver therapeutic deep tissue electrical signals to prevent pain signals from reaching the brain, helping to relieve chronic, acute or post-operative pain. Their technology has helped professionals, college athletes, veterans, and others suffering from chronic pain get closer to a pain-free life and return to daily activities without the use of opioids."

(To sign up for Norwalk breaking news alerts and more, click here.)

Murphy (D-Conn.) said, "The team at BioWave is transforming pain care management for the millions of Americans who suffer from chronic pain that interferes with their daily lives. Their technology provides a safe, effective alternative to opioids that helps ease persistent pain, and I’m proud to recognize their innovative work in Connecticut."

BioWave recently introduced a new patent pending product called BioWraps, which are wearable compression electrode garments that are paired with BioWave's pain blocking neurostimulators, according to the release.

BioWraps use a proprietary silver fabric technology that allows for treating up to five times the volume of tissue as compared to conventional electrodes while simultaneously providing compression and support.

"We are honored to be recognized by Senator Murphy," BioWave Founder Bradford Siff said in a news release. "One of the keys to innovation is having access to capital as well as to high level resources that can facilitate the ideation, design and development process. Being located in Connecticut helps provide easier access to capital and to these key individuals and core outside services. So for example, we were delighted to have the State of Connecticut’s venture capital arm, Connecticut Innovations, participate in our most recent round of preferred equity financing several years ago."